Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-14

Clinical Trial Update: Melanocyte Transplantation for Patients With Stable Vitiligo. [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of Phase 1 and Phase 2 studies evaluating melanocyte transplantation for stable vitiligo.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra | Conditions: Stable Vitiligo | Phase 1, Phase 2 | Status: COMPLETED